Fulminant liver failure secondary to submassive hepatic necrosis in a patient treated with Orlistat. A case report.
Rev Esp Enferm Dig
; 111(1): 83, 2019 Jan.
Article
em En
| MEDLINE
| ID: mdl-30325196
ABSTRACT
Orlistat is an intestinal lipase inhibitor drug that is recommended in obese patients along with a hypocaloric diet. Although the most frequent secondary effect is steatorrhea, fulminant liver failure has also been associated with this drug, which has required liver transplantation in 3 patients. We present the case of a 42-year-old obese male.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Falência Hepática Aguda
/
Fármacos Antiobesidade
/
Necrose Hepática Massiva
/
Fígado Gorduroso
/
Orlistate
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Rev Esp Enferm Dig
Assunto da revista:
GASTROENTEROLOGIA
Ano de publicação:
2019
Tipo de documento:
Article